I think Cytodyn is now on an upwards grind that will become self-perpetuating. Our imminent addition of 350m shares is now worth over $320m.

The higher the pps, the more those shares are worth...

The more financing we have, the more Cytodyn is likely to succeed...

The more it's derisked, the more shares people want...

Now the pps is even higher... rinse, repeat...

Now the 350m is worth $400m, then $500m, etc. etc.

In summary, up we go.